We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.75 | 17.50 | 18.00 | 17.75 | 17.75 | 17.75 | 47,325 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.25 | 16.19M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/8/2017 07:23 | Great find Someuwin, I had no idea how far forward this science and product was. | john henry | |
20/8/2017 22:28 | Fair enough! | shrewdmole | |
20/8/2017 22:24 | I have more than enough of these. | monkeywench1 | |
20/8/2017 21:57 | Monkey You mean to tell me you won't have a 50k order in at the opening bell? Shame on you. S | shrewdmole | |
20/8/2017 21:23 | Someuwin Great find. So the industry believes or knows the sugar work is about there..... For me that changes everything. I can see some serious action tomorrow. S | shrewdmole | |
20/8/2017 21:15 | Good find someuwin, so starting to see coverage now in the US and Asia. | parob | |
20/8/2017 21:10 | 'Asia's leading trade magazine for the food and beverage industry' | parob | |
20/8/2017 15:26 | OMG - My brain hurts. Kickingking, you have unwittingly proved my point. ;) | elrico | |
20/8/2017 15:04 | cheers Nick .. will keep u posted too | onedayrodders | |
20/8/2017 14:42 | The offer is correct. 25% off £133 is £100. When the offer is removed the price will go back up by 33% to £133. | kickingking | |
20/8/2017 14:20 | John - The offer for one week trial pack, was £55.49 now £41.50 and three week pack, was £133.50 now £100 can be found at It is a little confusing because the offer for the three as an example say 25% off, when in fact is 33%. The checkout also asks for a voucher code, but the price is reduced without the code. | elrico | |
20/8/2017 14:12 | Shrewdmole - The other point about multiple companies jostling for the same territory(s) - it plays into the hands of OPTI BOD when negotiating license fees; ie keeps margins high rather than lowering and the license fee is optimised. I envisage a time when we will get multiple commercial RNS's in a week for SweetBiotix, LP-LDL and SlimBiome. Though I wouldn't like to guess when these become a realistic occurrence, I don't see them being to many months away. As you rightly point out, the frequency of these will most likely increase over the next few months. The only fly in ointment for me, is the small team has a lot to handle and must prioritise business, which has a short term cost, but this method has greater control over costs, margins and license fees. A small price to pay. For our part, we just need to be patient and trust the BOD and science and ignore the noise a bluster around the share price | elrico | |
20/8/2017 13:44 | John Sorry it must of expired but was worth a go. Worth shopping around though or wait for the discount codes that filter through from go figure website, posters put the codes on here ASAP for others to share. I also tried the Shipley health store on line few weeks back, they had a promo on some flavours. GL | joyjoy13 | |
20/8/2017 13:00 | ODRodders, mine took almost a week to arrive.... started on them two days ago, also had blood test for cholesterol level done (waiting for result of that), and will be monitoring blood pressure during the course.... all really interesting! (must be an age thing!!!) | nicktopten | |
20/8/2017 12:48 | Elrico You have summed it up perfectly. Soh will be in discussions on several fronts and not just for lpldl territories there will be sugars discussions, go figure national retailer, Tata, etc etc Point is we don't have a clue how close any of them are or if we will get 5 Rns in a week. The company doesn't leak news so the first we will know is when the Rns start popping up. The thing is the frequency of the deals I suspect will be greater and greater as the science is out there and more products being sold. Eg imagine your trying to agree terms with Opti to for a territory for lpldl and you've seen the first supplier re order with 2 weeks? Knowing that there are multiple companies asking for similar regions it surely has to start to make them more likely to agree Optis terms. The tipping point isn't just about the science for me it's about acceptance of the commerciality of the products and all the time that is getting closer. Your right about too much expectation and wanting news now. However I don't think it's overly optimistic to assume we are in the throes of seeing the tipping point in the next few months so it could be very interesting here over the coming weeks and months. Like you say we could have news on any strain or all of them donuts exciting times. S | shrewdmole | |
20/8/2017 11:50 | Parob - I wouldn't concern yourself with the SP, technical ceilings, etc. What if the next two deals are nationals like PharaBio and HLH, in that they will only generate "moderate revenues in the first 12 months." Of course, these all build up nicely, validate the science further, build momentum, much like Malcolm Gladwell illustrates (thanks ZEBBO). IMHO we are in danger of building expectations much like our friend, TW. We are also in danger of being blindsided by SweetBiotix, and or TATA (nice:). SOH has previously said, he does not offer running commentary on progress due to NDA, etc, so we may think nothing is happening. TATA was reeled in on the back of GoFigure/SlimBiome RNS's. The recent SweetBiotix RNS, which offered incredible data the food, beverage and dairy industry are craving for, not to mention Stavia producers...I wonder how many enquiries the SweetBiotix/Reading taste test RNS attracted? | elrico | |
20/8/2017 11:14 | still waiting for my LPLD tablets ordered Tuesday looking forward to them being available in the UK | onedayrodders | |
20/8/2017 10:18 | I personally think it's going to take two more deals to break out above 85p. Never been so excited about a stock.With each and every deal:- the value of the strain increases- credibility of the science builds- awareness of the brand amongst both consumers and potential partners increases- consumer acceptance of the product builds- we take a step closer to a deal with a large consumer health business- revenues cumulatively build and we move closer to the inflection point and profitability | parob | |
20/8/2017 09:49 | I've been in Opti a long time but feel that right now is when things are really starting to hot up. I can remember when the share price hit 100p and yet I didn't sell any as I was expecting it to go even higher! It will be good when we reach this point again. This time it will be due to commercialisation deals rather than sole potential and hopefully it will therefore keep on rising. Hoe that doesn't sound like a ramp, it is in fact my genuine thoughts here. GLA. | bdog51 | |
20/8/2017 09:36 | Zebbo Completely agree with that thesis. Can't wait for Monday's start. Only few days left of August and then holidays over. September folk back to work and then next few months, I'd like to think more news. But I'm happy with how things are ticking over. I expect share price will still have a few ups and downs with day traders etc but for those who do the proper research will buy with the long term view, IMHO. Any newbies, great articles in the OPTI header here, mainly thanks to Elrico. GLA | joyjoy13 | |
20/8/2017 09:24 | 18081 Delighted to hear diet worked for you. Forgive me if I'm wrong, but wasn't that the name of the matches? If so, I'd take it as a compliment....chuckl Great achievement. P.s. Or as Zebbo would say above "Little things make a big difference" | joyjoy13 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions